Metabolic Effects and Hypoglycemia Risk As an insulin-like peptide, IGF-1 DES can lower blood glucose through enhanced glucose uptake, insulin-mimetic effects, improved insulin sensitivity, but risk of hypoglycemia at high doses
Clinical and experimental studies increasingly demonstrate that shifts in gut microbial composition are significantly correlated with hypothyroidism, underscoring the complexity and importance of this relationship (Liu Y
When GLP-1 medications activate these receptors, they may: Reduce the pleasurable effects of alcohol Decrease motivation to seek alcohol Lower overall reward-seeking behavior Help regulate impulse control A large Swedish study of approximately 228,000 people with alcohol use disorder found that those taking GLP-1 medications were less likely to be hospitalized for alcohol-related issues
it is now fighting a different fight
20 In another study, the data showed that the efficacy remained unchanged in the majority of patients
Am J Neuroradiol 32 , 633636 (2011)
